Logo

American Heart Association

  13
  0


Final ID: Sa1122

Association Between Imaging Follow Up and 1-Year Reintervention Risk After Peripheral Vascular Intervention for Claudicatio

Abstract Body (Do not enter title and authors here): Background: One-third of patients undergoing peripheral vascular intervention (PVI) for refractory claudication undergo a reintervention within 1 year. It is unknown whether receiving follow up imaging after PVI for claudication is associated with 1-year reintervention risk.
Aim: To assess the association between receiving imaging follow-up within 3 months after PVI for claudication and 1-year reintervention risk before occurrence of major amputation.
Method: We studied patients with claudication undergoing PVI who were alive and without reintervention at 3 months (2015-2018) in the Vascular Quality registry. Reintervention and imaging data were defined from Medicare data. Imaging follow-up included ankle brachial index (ABI), duplex ultrasound (DU), computed tomography angiography (CTA), and magnetic resonance angiogram (MRA) within 3 months post-PVI. We propensity-matched 1:1 for imaging follow-up status (No vs. Yes). The Aalen-Johansen method and Fine-Gray model assessed the 1-year cumulative incidence and reintervention risk (sub-hazard ratio, sHR) in patients without vs. with imaging follow-up, accounting for the competing mortality risk. Sensitivity analysis excluded ABI from imaging follow-up.
Results: Each imaging follow-up status included 2,208 patients. Mean age was 71.3±8.4 years and 39.0% female. In patients with imaging, 47.1% received 1 imaging test, of which 75.1% were ABIs. Over 50% received ≥2 imaging tests within 3 months post-PVI, with 5% receiving ≥1 per month. The 1-year cumulative incidence and reintervention risk was similar in patients without vs. with imaging (17.5% 95%CI 15.9-19.2 vs. 18.8% 95%CI 17.1-19.2 and sHR 0.92 95%CI 0.80-1.06, P=0.259). When excluding ABI, the 1-year cumulative incidence and reintervention risk was lower in those without vs. with imaging (18.3% 95%CI 16.6-20.2 vs. 21.1% 95%CI 19.2-23.0 and sHR 0.86 95%CI 0.74-0.99, P=0.039) (Figure).
Conclusion: Although over half of patients received multiple imaging tests within 3 months post-PVI for claudication, extensive imaging beyond ABI follow-up, was not associated with reintervention risk, which remained high with 1-year rates around 20%. Future efforts should study optimal imaging strategies and cost-benefit ratios.
  • Romain, Gaelle  ( Yale University , New Haven , Connecticut , United States )
  • Smolderen, Kim  ( Yale University , New Haven , Connecticut , United States )
  • Cleman, Jacob  ( Yale University , New Haven , Connecticut , United States )
  • Callegari, Santiago  ( Yale University , New Haven , Connecticut , United States )
  • Rahman, Mufti  ( Yale University , New Haven , Connecticut , United States )
  • Knight, Derek  ( Yale University , New Haven , Connecticut , United States )
  • Mena-hurtado, Carlos  ( Yale University , New Haven , Connecticut , United States )
  • Author Disclosures:
    Gaelle Romain: DO NOT have relevant financial relationships | Kim Smolderen: DO have relevant financial relationships ; Consultant:Terumo:Active (exists now) ; Consultant:Happify:Active (exists now) ; Research Funding (PI or named investigator):Philips:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):J&J:Active (exists now) ; Consultant:Cook:Active (exists now) | Jacob Cleman: No Answer | Santiago Callegari: DO NOT have relevant financial relationships | Mufti Rahman: DO NOT have relevant financial relationships | Derek Knight: No Answer | Carlos Mena-Hurtado: DO have relevant financial relationships ; Consultant:Cook:Active (exists now) ; Research Funding (PI or named investigator):Merck :Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):Shockwave:Active (exists now) ; Consultant:BD:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Lungs to Toes, WAZE Around Peripheral Clots and Blocks

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
3D Statistical Shape Analysis Predicts Type A Aortic Dissection Better Than Aortic Diameters

Marway Prabhvir, Campello Jorge Carlos Alberto, Wagner Catherine, Baker Timothy, Burris Nicholas

Bayesian modeling to forecast mortality due to Ischemic Heart Disease, Stroke, and Peripheral Artery Disease in Brazil until 2040

Vieira De Oliveira Salerno Pedro Rafael, Petermann-rocha Fanny, Deo Salil, Cotton Antoinette, Nascimento Bruno, Chen Zhuo, Tensol Rodrigues Pereira Gabriel, Abizaid Alexandre, Palma Dallan Luis Augusto, Salerno Pedro Rafael, Al-kindi Sadeer

More abstracts from these authors:
Association Between Diabetes and 5-year Mortality and Major Amputation Outcomes After Revascularization in Chronic Limb-threatening Ischemia

Callegari Santiago, Cleman Jacob, Rahman Mufti, Aggarwal Abhinav, Smolderen Kim, Mena-hurtado Carlos, Romain Gaelle

Association Between Guideline-directed Medical Therapy and Reintervention Risk at 2 Years Following Peripheral Vascular Interventions

Callegari Santiago, Cleman Jacob, Rahman Mufti, Capuano Isabella, Smolderen Kim, Mena-hurtado Carlos, Romain Gaelle

You have to be authorized to contact abstract author. Please, Login
Not Available